The effect of doxorubicin and retinoids on proliferation, necrosis and apoptosis in MCF-7 breast cancer cells

Folia Histochemica et Cytobiologica

Volumn 42, Issue 4, 2004, Pages 221-227

  Czeczuga Semeniuk, Ewa ^a   Wołczyński, Sławomir ^a   Dabrowska, Milena ^a   Dziecioł, Janusz ^a   Anchim, Tomasz ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

All trans retinoic acid; Apoptosis; Doxorubicin; Estradiol; MCF 7; Proliferation; Tamoxifen

Indexed keywords

ACRIDINE ORANGE; CYCLINE; DOXORUBICIN; DYE; ESTRADIOL; ESTROGEN RECEPTOR; KI 67 ANTIGEN; RETINOIC ACID; TAMOXIFEN; THYMIDINE; TRITIUM;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN MCF 7; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INCUBATION TIME; STATISTICAL SIGNIFICANCE;

MINK CELL FOCUS-FORMING VIRUS;

EID: 8344279570     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Barranco SC, Gerner EW, Burk KH, Humphrey RM (1973) Survival and cell kinetics effects of adriamycin on mammalian cells. Cancer Res 33: 11-16
2. Benchekroun MN, Robert J (1992) Measurement of a doxorubicin-induced lipid peroxidation under the conditions that determine cytotoxicity in cultured tumor cells. Anal Biochem 201: 326-330
3. Bontenbal M, Sieuwerts AM, Peters HA, Sonneveld P, Foekens JA, Klijn JGM (1990) Manipulation of cell cycle kinetics: influence of the cytotoxicity of doxorubicin in human breast cancer cells. J Steroid Biochem Molec Biol 37: 1097-1101
4. Bontenbal M, Sonneveld P, Foekens JA, Klijn JGM (1988) Oestradiol enhances doxorubicin uptake and cytotoxicity in human breast cancer cells, Eur J Cancer Clin Oncol 24: 1409-1414
5. Brenner DE, Galloway S, Cooper J, Noone R, Hande KR (1985) Improved high-performance liquid chromatography assay of doxorubicin: Detection of circulating aglycones in human plasma and comparison with thin-layer chromatography. Cancer Chemother Pharmacol 14: 139-145
6. Chambon P (1994) The retinoid signaling pathway: molecular and genetic analyses. Semin Cell Biol 5: 115-125
7. Chambon P (1995) The molecular and genetic dissection of the retinoid signalling pathway. Rec Prog Horm Res 50: 317-332
8. Ciftci K, Su J, Trovitch PB (2003) Growth factors and chemotherapeutic modulation of breast cancer cells. J Pharm Pharmacol 55: 1135-1141
9. Crawford KW, Bowen WD (2002) Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. Cancer Res 62: 313-322
10. Czeczuga-Semeniuk E, Anchim T, Dziecioł J, Dabrowska M, Wołczyński S (2004) Can transforming growth factor-β1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells? Acta Biochim Pol (in press)
11. Czeczuga-Semeniuk E, Wołczyński S, Anchim T, Dziecioł J, Dabrowska M, Pietruczuk M (2002) Effect of melatonin and all-trans retinoic acid on the proliferation and induction of the apoptotic pathway in the culture of human breast cancer cell line MCF-7. Pol J Pathol 53: 59-65
12. Czeczuga-Semeniuk E, Wołczyński S, Dziecioł J, Dabrowska M, Anchim T, Tomaszewska I (2001) 13-cis retinoic acid and all-trans retinoic acid in the regulation of the proliferation and survival of human breast cancer cell line MCF-7. Cell Biol Mol Lett 6: 925-939
13. De Gregorio MW, Ford JM, Benz CC, Wiebe VJ (1989) Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistance. J Clin Oncol 7: 1359-1364
14. Elmore LW, Rehder CW, Di X, McChesney PA, Jackson-Cook CK, Gewirtz DA, Holt SE (2002) Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction. J Biol Chem 277: 35509-35515
15. Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240: 889-895
16. Falkson G, Falkson CI, Falkson H (1992) Combination chemotherapy. In: Medical management of breast cancer. Powles TJ, Smith IE [Eds], Martin Dunitz, London, pp 139-151
17. Fornari FA, Randolph JK, Yalowich JC, Ritke MK, Gewirtz DA (1994) Interference with DNA unwinding by doxorubicin in MCF-7 breast tumor cells. Mol Pharmacol 45: 649-656
18. Gooch JL, Yee D (1999) Strain-specific differences in formation of apoptotic DNA ladders in MCF-7 breast cancer cells. Cancer Lett 144: 31-37
19. Gosalvez M, Van Rossum GD, Bianco MF (1979) Inhibition of sodium-potassium-activated adenosine 5′-triphosphatase and ion transport by adriamycin. Cancer Res 39: 257-261
20. Gudas LJ (1994) Retinoids and vertebrate development. J Biol Chem 269: 15399-15402
21. Hug V, Johnston DT, Finders M, Hortobagyi G (1986) Use of growth-stimulatory hormones to improve the in vitro therapeutic index of doxorubicin for human breast tumors. Cancer Res 46: 147-152
22. Kaleagasioglu F, Doepner G, Biesalski HK, Berger MR (1993) Antiproliferative activity of retinoic acid and some novel retinoid derivatives in breast and colorectal cancer cell lines of human origin. Arzneim Forsch 43: 487-490
23. Krinsky NI, Wang X-D, Tang G, Russell RM (1993) Mechanism of carotenoid cleavage to retinoids. In: Carotenoids in Human Health. Canfield LM, Krinsky NI, Olson JA [Eds], New York, The New York Academy of Sciences, New York, pp 167-176
24. Kurbacher ChM, Wagner U, Kolster B, Andreotti PE, Krebs D, Bruckner HW (1996) Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett 103: 183-189
25. Lacroix A, Lippman ME (1980) Binding of retinoids to human breast cancer cell lines and their effects on cell growth. J Clin Invest 65:586-591
26. Lang Y-H, Priebe W, Perez-Soler R (1993) Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res 53: 1845-1852
27. Leid M, Kastner P, Chambon P (1992) Multiplicity generates diversity in the retinoic acid signaling pathways. Trends Biochem Sci 17: 427-433
28. Lotan R (1979) Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibition. Cancer Res 39: 1014-1019
29. McCormick AM, Napoli JL (1982) Identification of 5,6-epoxy retinoic acid as an endogenous retinol metabolite. J Biol Chem 257: 1730-1735
30. Momparler RL, Karon M, Siegel SE, Avila F (1976) Effect of adriamycin on DNA, RNA and protein synthesis in cell-free systems and intact cells. Cancer Res 36: 2891-2895
31. Myers C (1997) Anthracyclines and DNA intercalators. In: Cancer medicine. Holland JF, Frei E, Bast RC Jr [Eds], Williams & Wilkins, Philadelphia, pp 977-988
32. Napoli JL (1993) Biosynthesis and metabolism of retinoic acid: roles of CRBP and CRABP in retinoic acid homeostasis. J Nutr 123: 362-366
33. Nass SJ, Li M, Amundadottir LT, Furth PA, Dickson RB (1996) Role for BCL-xL in the regulation of apoptosis by EGF and TGFbeta1 in c-MYC overexpressing mammary epithelial cells. Biochem Biophys Res Commun 227: 248-256
34. Panasci L, Jean-Claude BJ, Vasilescu D, Mustafa A, Damian S, Damian Z, Georges E, Liu Z, Batist G, Leyland-Jones B (1996) Sensitization to doxorubicin resistance in breast cancer cell lines by tamoxifen and megestrol acetate. Biochem Pharmacol 52: 1097-1102
35. Raghunand N, He X, van Sluis R, Mahoney B, Baggett B, Taylor CW, Paine-Murrieta G, Roe D, Bhujwalla ZM, Gillies RJ (1999) Enhancement of chemotherapy by manipulation of tumour pH. Br J Cancer 80: 1005-1011
36. Rasbridge SA, Gillett CE, Seymour A-M, Patel K, Richards MA, Rubens RD, Millis RR (1994) The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma. Br J Cancer 70: 335-341
37. Robert J, Illiadis A, Hoerni B, Cano J, Durand M, Lagarde C (1982) Pharmacokinetics of adriamycin in patients with breast cancer: correlation between pharmacokinetic parameters and clinical short-term response. Eur J Cancer Clin Oncol 18: 739-745
38. Rubens RD (1992) Single-agent chemotherapy. In: Medical management of breast cancer. Powles TJ, Smith IE [Eds], Martin Dunitz, London, pp 131-137
39. Shaikh NA, Owen AM, Ghilchik M, Braunsberg H (1989) Adriamycin action on human breast cancer cells: enhancement by medroxyprogesterone acetate. Int J Cancer 43: 733-736
40. Siegfried JA, Kennedy KA, Sartorelli AC, Tritton TR (1983) The role of membranes in the mechanism of action of the antineoplastic agent adriamycin. J Biol Chem 258: 339-343
41. Sinha BK, Katki AG, Batist G, Cowan KH, Myers ChE (1987) Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of action. Biochemistry 26: 3776-3781
42. Skladanowski A, Konopa J (1993) Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumor cells. Biochem Pharmacol 46: 375-382
43. Sporn M, Roberts AB (1983) Role of retinoids in differentiation and carcinogenesis. Cancer Res 43: 3034-3040
44. Takatsuka J, Takahashi N, De Luca LM (1996) Retinoic acid metabolism and inhibition of cell proliferation: an unexpected liaison. Cancer Res 56: 675-678
45. Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF (1984) Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226: 466-468
46. Toma S, Maselli G, Dastoli G, De Francisci E, Raffo P (1997) Synergistic effect between doxorubicin and a low dose of all-trans retinoic acid in MCF-7 breast cancer cell line. Cancer Lett 116: 103-110
47. Van der Leede B-J, Folkers GE, van den Brink CE, Van den Saag PT, Van der Burg B (1995) Retinoic acid receptor α isoform is induced by estradiol and confers retinoic acid sensitivity in human breast cancer cells. Mol Cell Endocrinol 109: 77-86
48. Vichi P, Tritton TR (1989) Stimulation of growth in human and murine cells by adriamycin. Cancer Res 49: 2679-2682
49. 3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Res 60: 2040-2048
50. Woods K, Randolph JK, Gewirtz DA (1994) Antagonism between tamoxifen and doxorubicin in the MCF-7 human breast tumor cell line. Biochem Pharmacol 47: 1449-1452
51. Zhu W-Y, Jones CS, Kiss A, Matsukuma K, Amin S, De Luca LM (1997) Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells. Exp Cell Res 234: 293-299
52. Zoli W, Ricotti L, Barzanti F, Dal Susino M, Frassineti GL, Milandri C, Casadei Giunchi D, Amadori D (1999) Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines. Int J Cancer 80: 413-416
53. Zunino F, Gambetta R, DiMarco A (1975) The inhibition in vitro of DNA polymerase and RNA polymerases by daunomycin and adriamycin. Biochem Pharmacol 24: 309-311